<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref20">
 <mixed-citation publication-type="journal" id="cit20">
  <name>
   <surname>Gaikwad</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Ingle</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Gade</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Rai</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Falanga</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Incoronato</surname>
   <given-names>N.</given-names>
  </name>; 
  <name>
   <surname>Russo</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Galdiero</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Galdiero</surname>
   <given-names>M.</given-names>
  </name>
  <article-title>Antiviral Activity of Mycosynthesized Silver Nanoparticles against Herpes Simplex Virus and Human Parainfluenza Virus Type 3</article-title>. 
  <source>Int. J. Nanomed.</source>
  <year>2013</year>, 
  <volume>8</volume>, 
  <fpage>4303</fpage>â€“
  <lpage>4314</lpage>. 
  <pub-id pub-id-type="doi">10.2147/IJN.S50070</pub-id>.
 </mixed-citation>
</ref>
